If you were successfully sent a Fax, on or about February 7, 2020, that states “Medical Record Review of the Impact of Adverse Events Associated with the Use of Current anti-Parkinson’s Disease Medications on Patient Clinical Therapeutics and Outcomes Trajectories in the U.S,” and offers an honorarium of $250 per eligible patient, your rights may be affected by a proposed class action settlement.
Plaintiff Progressive Health and Rehab Corp. (“Plaintiff”) filed this class action lawsuit alleging that Defendants Indegene, Inc., Indegene Encima, Inc., Indegene Wincere Incorporated, and Indegene Healthcare, LLC (“Defendants”) violated the federal Telephone Consumer Protection Act (“TCPA”), 47 U.S.C. § 227, by sending advertisements to the Settlement Class by fax without express invitation or permission. The Defendants deny Plaintiff’s allegations, deny any wrongdoing occurred, and raised defenses.
This website is provided as a service to class members. The information provided is in summary form and is not intended as a complete explanation of your rights. For full and complete information, you are directed to review carefully the Notice of Class Action Settlement.